In the group of ovarian cancer patients subjected to neoadjuvant chemotherapy Kaplan-Meier curves demonstrated that high baseline TIMP3 levels were associated with total patient survival time longer by 12.4 months. Here, TIMP3 is linked to ovarian cancer.